Meet Ashley Aaroe, M.D.
Ashley E. Aaroe, M.D.
Department of Neuro-Oncology, Division of Cancer Medicine
About Dr. Ashley E. Aaroe
Dr. Aaroe earned her medical degree from the Northwestern University Feinberg School of Medicine in 2015. She subsequently completed a residency in neurology at the New York-Presbyterian Hospital, Weill Cornell Medical Center. Prior to her recruitment to the Department of Neuro-Oncology at MD Anderson, she completed fellowship training at MD Anderson. She is board certified in Neurology by the American Board of Psychiatry and Neurology, and in Neuro-Oncology by the United Council for Neurologic Subspecialties.
Her clinical interests include the management of primary and metastatic brain tumors, and neurological complications of cancer and cancer therapy. She has served on the editorial board of Continuum and as a reviewer for Neurology. She is member of several professional societies including the Society for Neuro-Oncology (SNO) where she serves on the public policy committee and the American Academy of Neurology (AAN) where she is active in medical education. In addition to her clinical and research activities she is passionate about physician advocacy and regularly participates in events with policymakers on behalf of the AAN and the National Brain Tumor Society (NBTS). Dr. Aaroe currently serves as faculty representative for the Patient Reported Outcomes (PRO) program at the Brain and Spine Center facilitating collection and interpretation of data regarding patient symptom burden and overall quality of life.
In the News
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Neuro Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2015 | Northwestern University, Feinberg School of Medicine, Chicago, Illinois, US, M.D |
| 2011 | Johns Hopkins University, Baltimore, Maryland, US, Neuroscience, B.A |
Postgraduate Training
| 2019-2021 | Clinical Fellowship, Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2017-2019 | Clinical Residency, Neurology, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York |
| 2015-2017 | Clinical Internship, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York |
Licenses & Certifications
| 2021 | United Council of Neurological Subspecialties |
| 2021 | Texas Medical License |
| 2019 | American Board of Psychiatry and Neurology |
Experience & Service
Administrative Appointments/Responsibilities
Vizient Champion, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Advanced Practice Provider Faculty Liaison, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Cancer Neuroscience Program Steering Committee, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - 2024
Brain Tumor Center Patient Reported Outcomes Faculty Liaison, The University of Texas MD Anderson Cancer Center, 2021 - Present
Extramural Institutional Committee Activities
Immuno-oncology Toxicity (IOTOX) Neurotoxicity Consultant, IOTOX Peer-to-Peer Program, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, INSCOPE (Improving Neuro Services Clinical Operations & Practice Efficiency), The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, IOTOX Clinical Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Academic Mentoring Council, The University of Texas MD Anderson Cancer Center, 2024 - 2025
Member, Graduate Medical Education Committee - MD Anderson, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Member, GME Wellness Subcommittee, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Ex-officio Advisor, MD Anderson House Staff Senate, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Cancer Neurology Representative, Brain Tumor Center Executive Committee, The University of Texas MD Anderson Cancer Center, 2021 - 2025
Award Reviewer, 2022 MD Anderson Distinguished Alumni, The University of Texas MD Anderson Cancer Center, 2021 - 2021
Panel Reviewer, Divisional Faculty Recognition & Awards Program, The University of Texas MD Anderson Cancer Center, 2021 - 2021
Member-at-Large, MD Anderson House Staff Senate, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Trainee Representative, Brain Tumor Center Executive Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Leadership Training Task Force - MD Anderson, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Career Development Task Force - MD Anderson, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Brain Tumor Center Scientific Retreat Planning Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Research Task Force - MD Anderson, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Editorial Activities
Editor/Service on Editorial Board(s), Continuum: The Continuing Medical Education Journal of the American Academy of Neurology, 2020 - 2021
Honors & Awards
| 2024 - Present | Future Leaders Development Program Scholar, Society for Neuro-Oncology |
| 2021 - Present | Clinical Safety and Effectiveness Course Certificate, MD Anderson Office of Performance Improvement |
| 2021 - Present | Six Sigma Yellow Belt Certificate, MD Anderson Office of Performance Improvement |
| 2021 - Present | Applying Lean Concepts to Healthcare Processes Introductory Level, MD Anderson Office of Performance Improvement |
| 2021 | David C. Leach Award - Awarded to MD Anderson House Staff Senate Officers, Accreditation Council for Graduate Medical Education |
| 2021 | Trainee Leadership Certificate, MD Anderson Leadership Institute |
| 2019 | Neurology Resident Teaching Award, New York-Presbyterian Hospital |
| 2019 | Employee of the Month - House Staff, New York-Presbyterian Hospital |
| 2015 | Medical Student Prize for Excellence, American Academy of Neurology (AAN) |
| 2010 | Refresh Everything National Grant Program Winner, Pepsi Co |
| 2009 | Macklin Fellowship for Ataxia Edification, The Gordon and Marilyn Macklin Foundation |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Acute Ischemic Stroke in Cancer: Challenges and Opportunities. Invited. Institutional Grand Rounds. Houston, TX, US.
- 2021. Diffuse Leptomeningeal Glioneuronal Tumors. Invited. Brain Tumor Program Seminar Series. Houston, TX, US.
- 2020. D3CODE. Invited. Ken Kennedy Institute Data Science Conference. Houston, TX, US.
Regional Presentations
- 2023. Primary Brain Tumors – Advances and Frontiers. Invited. Advances in Neurology Symposium, US.
- 2023. Neurological Complications of Cancer. Conference. NeuroICU Symposium, US.
National Presentations
- 2024. What happens if my tumor comes back?. Invited. National Conference, US.
Grant & Contract Support
| Date: | 2024 - Present |
| Title: | Neuro-Oncologic Clinical Research with Emphasis on Disparities in Primary Brain Tumors |
| Funding Source: | National Center for Advancing Translational Sciences - |
| Role: | PI |
| ID: | 1L30TR005243-01 |
Selected Publications
Peer-Reviewed Articles
- Yeboa, DN, Whitfield, BT, Lin, R, Ejezie, CL, Swanson, T, Beckham, TH, Wang, C, De, BS, Perni, S, Tom, MC, Li, J, McGovern, SL, Harrison, R, Majd, NK, Puduvalli, VK, Aaroe, AE, Loghin, ME, O'Brien, BJ, Patel, AD, Patel, C, Wefel, JS, Taslicay, CA, Gule-Monroe, MK, Paulino, AC, McAleer, MF, Grosshans, DR, Ghia, AJ, Jiang, W, Chung, C, Maor, MM, Yang, CH, Gubbiotti, M, Kamiya Matsuoka, C, Ballester, L, Weathers, S, Huse, J. Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses. Journal of neuro-oncology 176(1), 2026. e-Pub 2026. PMID: 41191157.
- Grippin, A, Marconi, C, Copling, S, Li, N, Braun, C, Rooney, M, Schrank, B, Gladish, G, Vaporciyan, AA, Johns, AC, Subbiah, IM, Aloia, TA, Wu, J, Wu, CC, Woodman, SE, Weinstein, JN, Tawbi, H, Shete, S, Scheet, PA, Ravi, V, Palaskas, NL, Nates, JL, Muthu, M, Musunuru, TN, McEnery, KW, Litton, J, John, TM, Jaffray, D, Hutcheson, KA, Gunther, J, Godoy, M, Futreal, A, French, KE, Draetta, G, Dabaja, BS, Crommett, JW, Cata, JP, Brock, K, Beird, H, Aaroe, AE, Lee, JJ, Sun, R, Sharma, P, Tran, HT, Zhang, J, Gibbons, DL, Wargo, J, Heymach, JV, Jiang, W, Lin, SH. SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature 647(8089):488-497, 2025. e-Pub 2025. PMID: 41125896.
- Lam, K, Nasr, L, Andersen, C, Marqueen, KE, Li, J, Wang, C, Beckham, TH, Majd, NK, Aaroe, AE, Loghin, ME, O'Brien, BJ, McGovern, SL. Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid Tumors. Advances in Radiation Oncology 10(2), 2025. e-Pub 2025. PMID: 39866593.
- Pham, L, Weller, L, Gann, CN, Schumacher, K, Vlassak, S, Swanson, T, Highsmith, KN, O’Brien, BJ, Nash, S, Aaroe, AE, De Groot, J, Majd, NK. Prolonged complete response to adjuvant tepotinib in a patient with newly diagnosed disseminated glioblastoma harboring mesenchymal-epithelial transition fusion. Oncologist 30(1), 2025. e-Pub 2025. PMID: 38815166.
- Gregory, TA, Knight, SR, Aaroe, AE, Highsmith, KN, Janatpour, ZC, O’Brien, BJ, Majd, NK, Loghin, ME, Patel, C, Weathers, S, Puduvalli, VK, Kamiya Matsuoka, C. Accelerated tumor progression after COVID-19 infection in patients with glioblastoma. Neuro-Oncology Practice 11(4):475-483, 2024. e-Pub 2024. PMID: 39006516.
- Majd, NK, Yeboa, DN, Wang, S, Weathers, S, Yuan, Y, Al Anssari, H, Kamiya Matsuoka, C, O'Brien, BJ, Aaroe, AE, Patel, C, Dagher, SA, Wintermark, M, Ferguson, SD, Puduvalli, VK, Liu, SJ, Raleigh, D, de Groot, JF. Phase I clinical trial of peposertib plus radiation in adults with newly diagnosed MGMT-unmethylated glioblastoma. Journal of Clinical Oncology 42(16_suppl):2076, 2024. e-Pub 2024.
- Simbaqueva C, Aaroe AE, Rubio D, Loghin M, Treiber J, Ballester L, Fuller G, Gopakumar S, Kim Betty YS, Suarez-Almazor. Leptomeningeal Immunoglobulin G4–Related Disease: A Case Report. Annals of Internal Medicine: Clinical Cases 2(12), 2023. e-Pub 2023.
- Aaroe A, Kurzrock R, Goyal G, Goodman AM, Patel H, Ruan GJ, Ulaner G, Young JR, Li Z, Dustin D, Go RS, Diamond EL, Janku F. Successful Treatment of Non-Langerhans Cell Histiocytosis with the MEK Inhibitor Trametinib: A Multicenter Analysis. Blood Adv 7(15):3984-3992, 2023. e-Pub 2023. PMID: 36857436.
- Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
- Michaelson NM, Aaroe AE, Lewis SL, Safdieh JE. Emerging Subspecialties in Neurology: Becoming an Editor-In-Chief. Neurology 97(20):e2046-e2049, 2021. e-Pub 2021. PMID: 34376514.
- Aaroe AE, Glitza Oliva IC, Al-Zubidi N, Nader ME, Kaya D, Ferguson SD, Wang C, Fuller G, Harrison RA. Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis. Neurology 97(5):248-250, 2021. e-Pub 2021. PMID: 33931525.
- Kummer BR, Diaz I, Wu X, Aaroe AE, Chen ML, Iadecola C, Kamel H, Navi BB. Associations between cerebrovascular risk factors and parkinson disease. Ann Neurol 86(4):572-581, 2019. e-Pub 2019. PMID: 31464350.
Review Articles
- Mohammed, C, Aaroe, AE, Buchold, G, Krummel, DA, Stamets, P, Sharma, A, Alschuler, L, Sengupta, S. Fungal-derived supplements in integrative oncology. American Journal of Medicine 139(4):530-537, 2026. e-Pub 2026. PMID: 41534686.
- Keam, S, Turner, N, Grande Kugeratski, F, Rico, R, Colunga-Minutti, JG, Poojary, R, Alekseev, S, Patel, A, Li, YJ, Sheshadri, A, Loghin, ME, Woodman, K, Aaroe, AE, Hamidi, S, Iyer, PC, Palaskas, NL, Wang, Y, Nurieva, R. Toxicity in the era of immune checkpoint inhibitor therapy. Frontiers in immunology 15, 2024. e-Pub 2024. PMID: 39247203.
- Alsalem, AN, Scarffe, LA, Briemberg, H, Aaroe, AE, Harrison, R. Neurologic Complications of Cancer Immunotherapy. Current Oncology 30(6):5876-5897, 2023. e-Pub 2023. PMID: 37366923.
- Sharma P, Aaroe A, Liang J, Puduvalli VK. Tumor microenvironment in glioblastoma: Current and emerging concepts. Neurooncol Adv 5(1):vdad009, 2023. e-Pub 2023. PMID: 36968288.
- Aaroe AE, Nevel KS. Central Nervous System Involvement of Natural Killer and T Cell Neoplasms. Curr Oncol Rep 21(5):40, 2019. e-Pub 2019. PMID: 30919085.
Editorials
- Aaroe AE. Arts and Ataxia: Inspiring Activism through Art. Johns Hopkins Undergraduate Public Health Research Journal: Epidemic Proportions 8(1), 2011.
Abstracts
- Conley A, Li L, Livingston JA, Bishop A, Grosshans D, Ghia A, Grace M, Khanduri I, Lang W, Bird J, Alvarez-Breckeridge C, Raza S, Rhines L, DeMonte F, Lazar A, Wang WL, Aaroe A, Lin H, Roszik J, Amini B, Yevich S, Levy J, Sommer J, Freed D, Akdemir KC, Puduvalli V, Patel S. A PHASE 2 TRIAL OF CETUXIMAB FOR PATIENTS WITH LOCALLY ADVANCED/METASTATIC CHORDOMA. Abstract presentation at Connective Tissue Oncology Society Annual Meeting 2021, 2022. e-Pub 2022.
- Aaroe AE, Tummala S. Fixed ptosis as a symptom of myositis secondary to checkpoint inhibition. Poster presentation at Society for Neuro-Oncology Annual Meeting, 2021. e-Pub 2021.
- Aaroe AE, Sarkar S, Sherani S, McAleer M, Fuller G, Zaky W. SHH-driven medulloblastoma with concurrent unilateral renal agenesis. Poster presentation at Society for Neuro-Oncology Pediatric Neuro-Oncology Research Conference, 2021. e-Pub 2021.
- Aaroe AE, Ou A, McGovern S, Paulino A, Johnson J, Huse J, Fuller G, de Groot J, Walter A, Zaky W. Diffuse leptomeningeal glioneuronal tumor: a case series. Poster presentation at Society for Neuro-Oncology Pediatric Neuro-Oncology Research Conference, 2021. e-Pub 2021.
- Pham L, Gann C, Schumacher K, Vlassak S, Swanson T, Highsmith K, Ou A, Clarke N, Aaroe AE, Robell L, O’Brien B, Nash S, DeGroot JD, Majd N. Complete Response to Adjuvant Teopotinib in a Patient with Newly Diagnosed disseminated Glioblastoma (GBM) Harboring MET Amplification. Poster presentation at Society for Neuro-Oncology Annual Meeting, 2021. e-Pub 2021.
- Aaroe AE, Glitza Oliva IC, Nader ME, Kaya D, Ferguson S, Wang C, Fuller G, Harrison RA, Al-Zubidi N. Primary Pineal Melanoma with Leptomeningeal Carcinomatosis. Poster Presentation at North American Neuro-Ophthalmology Society Meeting, 2021. e-Pub 2021.
- Aaroe AE, Team D, Harrison R, Majd N, O’Brien B, Weathers S, Loghin M, Kamiya-Matsuoka C, Yung WK, de Groot J, Woodman K. A snapshot of the impact of COVID-19 on patients with nervous system tumors. Poster Presentation at Society for Neuro-Oncology Annual Meeting 2020 and MD Anderson Brain Tumor Center Scientific Retreat 2020, 2020. e-Pub 2020.
- Aaroe AE, Dono A, Youssef M, Alfaro-Munoz K, Liao E, Weathers S, O’Brien B, Majd N, Harrison R, Loghin M, Soomro Z, Williford G, Fuller G, Yung WK, Yeboa D, Esquenazi Y, Ballester L, de Groot J, Kamiya-Matsuoka C. A retrospective study of treatment strategies and outcomes in WHO grade II and III isocitrate dehydrogenase (IDH) wild-type astrocytoma. Poster Presentation at Society for Neuro-Oncology Annual Meeting, 2020. e-Pub 2020.
- Aaroe AE, Alfaro-Munoz K, Bornstein C, Chen M, Woodman K, Tummala S, Kleiman A, de Groot J, Loghin M. A retrospective single-center experience with nonbacterial thrombotic endocarditis and stroke - outcomes, anticoagulation strategies, and incorporation of next-generation sequencing data. Poster Presentation at Society for Neuro-Oncology Annual Meeting, 2020. e-Pub 2020.
- Kummer BR, Aaroe AE, Kamel H, Iadecola C, Navi B. Associations between Parkinson Disease and Stroke. Poster Presentation at American Academy of Neurology Annual Meeting, 2017. e-Pub 2017.
- Blizinsky K, Aaroe AE, Gejman P, Sanders A, Duan J, Penzes P, Wang L. A novel bioinformatic approach for the identification of CNV risk elements: application to 16p11.2 structural rearrangements in schizophrenia. Poster Presentation at International Congress on Schizophrenia Research, 2012. e-Pub 2012.
Book Chapters
- Weathers SP, O'Brien B, Aaroe AE, Yeboa DN, Prabhu S, de Groot JF. Tumors of the Central Nervous System. In: The MD Anderson Handbook of Medical Oncology. 4, 2022.
- Aaroe AE, Henchcliffe C. Promises and challenges of MSC-based therapies: Parkinson's Disease and Parkinsonism. In: A Roadmap to Non-hematopoietic Stem Cell-Based Therapeutics: from the bench to the clinic, 2018.
- Aaroe AE. Altered Mental Status and Syncope. In: Oncology Hospital Medicine: A Guide for Frontline Clinicians.
Letters to the Editor
- Aaroe AE, Majd N, Weathers SP, de Groot JF. Potential neurologic and oncologic implications of the novel coronavirus. Neuro Oncol 22: 1050-1051, 2020.
Web Publications
- Aaroe AE. Neurology on the Hill: My Role as an Advocate for Neurology.
Patient Reviews
CV information above last modified March 24, 2026